Skip to main content
Signal8

Nyxoah SA (NYXH) Form 6-K — Jul 9, 2026

$NYXHForm 6-KFiled Jul 9, 2026, 4:30 PM ET0001104659-26-082287Original filing

Nyxoah reported preliminary second quarter 2026 global net revenue of €7.7 million, representing 21% sequential growth, driven by a 22% increase in U.S. net revenue to €5.2 million. The company reaffirmed its full-year 2026 global net revenue guidance range of €36 million to €40 million. The company significantly strengthened its balance sheet, securing $110 million in aggregate financing during the quarter and ending June 30, 2026, with approximately €97.8 million in cash, cash equivalents, and financial assets.

Key figures

Revenue
€7.7 million
Guidance
€36 million to €40 million
Cash Position
€97.8 million
Shares Outstanding
100,072,815
Us Revenue
€5.2 million
Financing Secured
$110 million
Total Active Accounts
180
Total Surgeons Trained
262
Sequential Revenue Growth US
22%
Sequential Revenue Growth Global
21%

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Nyxoah SA (NYXH) Form 6-K — Jul 9, 2026: AI Analysis | Signal8